What name would you give this invasive breast carcinoma #breastpath

#RookiePathologyPGY1Mistakes Differentiating IDC from DCIS with lobular cancerization; p63 staining at low power may be misleading, particularly when invasive carcinoma cells aberrantly express p63. This can result in misclassification as DCIS #breastpath

Utility of E-cadherin, Is morphology good enough for Invasive ductal carcinoma? #breastpath

Utility of E-cadherin. Is morphology good enough for Invasive lobular carcinoma? #breastpath

Invasive breast carcinoma involving the fibroadenoma with extensive lymphovascular space invasion #breastpath

Utility of E-cadherin. 1) How would you interpret this E-cadherin staining pattern? 2) Will you call invasive lobular carcinoma? #breastpath

Thank you, Charlotte S. Taylor, for an exceptional lecture on effective presentation skills! Your significant contributions to the education of our residents are greatly appreciated.😊😊😊

🎉 Congratulations to our graduating residents Navdeep, Selcuk, and Nazar! Your hard work has paid off, and we can’t wait to see the amazing things you’ll achieve. Best of luck on your next adventures!

50/F with palpable breast mass with p63 loss (no brown stain) and Keratin (red) is shown. You call cancer: Patient gets mastectomy. You call benign nothing happens. What would you call? #breastpath